immunosuppressants (Poseidon/Pharmexa)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameimmunosuppressants (Poseidon/Pharmexa)
Drug Alias Nameimmunosuppressants (Pharmexa/Poseidon)potassium channel modulators (Poseidon/Pharmexa)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel modulators
TargetsPotassium channel
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPoseidon Pharmaceuticals A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A